Development of a novel duplex lateral flow test for simultaneous detection of casein and ß-lactoglobulin in food

Milk by-products such as whey and caseinate are widely used as ingredients or processing aids in food industry. However, since they could cause allergic reactions they are included in Allergen Control Plans. ß-Lactoglobulin is the major whey protein and caseins are main proteins in milk. Selection of a unique target to analyze the presence of milk in foods could be insufficient when the source of milk proteins is unknown. A new test based on lateral flow immunocromatography that combines the simultaneous and independent detection of both proteins (ß-lactoglobulin and casein)in one rapid test was developed. The assay was validated according to AOAC guidelines being able to detect ß-lactoglobulin (0.5 ppm), casein (2 ppm), whey and powder milk (1–5 ppm). No cross-reactivity was found with a panel of 38 food commodities. The method is a rapid and suitable tool to identify milk proteins in processed food, ingredients, and rinsing water

Development and validation of sensitive and rapid immunoassays to detect minute amounts of hazelnut in processed food and working surfaces

Hazelnut (Corylus avellana L.) represents one of the most allergenic nuts and it can be found as a hidden allergen in processed food due to cross contamination. Therefore, sensitive and specific analytical techniques are in high demand to be used in allergen risk management plans at food industry. In this study, sandwich ELISA and Lateral Flow Immunoassay (LFIA) to detect hazelnut have been developed based on the determination of Cor a 9, one of the most abundant and allergenic proteins of hazelnut. Results showed that cross-reactivity was only found with walnut and Pecan nut, which was lower than 0.1%. When analyzing food spiked with a hazelnut extract or blended with hazelnut flour, ELISA and LFIA were able to detect 0.1 ppm and 0.5 ppm of hazelnut protein with a recovery from 82 to 110%. ELISA and LFIA could also detect 0.15 and 0.6 ppm of hazelnut protein in baked cookies incurred with ground hazelnut, respectively. Furthermore, LFIA could detect 1.25 μg of hazelnut protein in working surfaces of stainless steel and melamine. The sandwich ELISA was in-house validated, showing acceptable results of precision. Likewise, ELISA and LFIA showed to be robust tests. The combined use of both assays could improve the allergen risk management plans in food industry to monitor the presence of hazelnut traces in raw ingredients, processed food and working surfaces

Sensitive ELISA and lateral flow immunoassay for the detection of walnut traces in processed food and working surfaces

Walnut represents one of the most allergenic nuts that can be found as a hidden allergen. In this study, sandwich ELISA and lateral flow immunoassay (LFIA), based on the determination of Jug r 1, were developed to detect walnut. Cross-reactivity was only found with Pecan nut among a panel of 88 food ingredients tested. ELISA and LFIA could detect 0.25 and 0.5 µg/g of walnut protein in complex food matrices spiked with walnut extract, respectively. Furthermore, walnut was detected in blended (chocolate) and incurred foods (ice cream and bread) added with ground walnut at levels of 0.5 and 1.5 µg protein/g by ELISA and LFIA, respectively. LFIA could also detect 0.1 μg of walnut protein in working surfaces. ELISA displayed acceptable precision and high recovery (71–97 %) and both tests were robust. This study shows that developed ELISA and LFIA are reliable tools to be applied in allergen control programs

Worldwide Disparities in Recovery of Cardiac Testing 1 Year Into COVID-19

BACKGROUND The extent to which health care systems have adapted to the COVID-19 pandemic to provide necessary cardiac diagnostic services is unknown.OBJECTIVES The aim of this study was to determine the impact of the pandemic on cardiac testing practices, volumes and types of diagnostic services, and perceived psychological stress to health care providers worldwide.METHODS The International Atomic Energy Agency conducted a worldwide survey assessing alterations from baseline in cardiovascular diagnostic care at the pandemic's onset and 1 year later. Multivariable regression was used to determine factors associated with procedure volume recovery.RESULTS Surveys were submitted from 669 centers in 107 countries. Worldwide reduction in cardiac procedure volumes of 64% from March 2019 to April 2020 recovered by April 2021 in high- and upper middle-income countries (recovery rates of 108% and 99%) but remained depressed in lower middle- and low-income countries (46% and 30% recovery). Although stress testing was used 12% less frequently in 2021 than in 2019, coronary computed tomographic angiography was used 14% more, a trend also seen for other advanced cardiac imaging modalities (positron emission tomography and magnetic resonance; 22%-25% increases). Pandemic-related psychological stress was estimated to have affected nearly 40% of staff, impacting patient care at 78% of sites. In multivariable regression, only lower-income status and physicians' psychological stress were significant in predicting recovery of cardiac testing.CONCLUSIONS Cardiac diagnostic testing has yet to recover to prepandemic levels in lower-income countries. Worldwide, the decrease in standard stress testing is offset by greater use of advanced cardiac imaging modalities. Pandemic-related psychological stress among providers is widespread and associated with poor recovery of cardiac testing. (C) 2022 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation